Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Kane Biotech Total Liabilities (Quarterly) : 3.229M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.229M |
| September 30, 2025 | 3.534M |
| June 30, 2025 | 4.046M |
| March 31, 2025 | 3.890M |
| December 31, 2024 | 4.123M |
| September 30, 2024 | 4.594M |
| June 30, 2024 | 4.796M |
| March 31, 2024 | 15.33M |
| December 31, 2023 | |
| September 30, 2023 | 13.02M |
| June 30, 2023 | 11.83M |
| March 31, 2023 | 10.88M |
| December 31, 2022 | 9.758M |
| September 30, 2022 | 9.923M |
| June 30, 2022 | 9.750M |
| March 31, 2022 | 8.281M |
| December 31, 2021 | 7.701M |
| September 30, 2021 | 6.993M |
| June 30, 2021 | 5.434M |
| March 31, 2021 | 4.151M |
| December 31, 2020 | 3.961M |
| September 30, 2020 | 2.913M |
| June 30, 2020 | 2.515M |
| March 31, 2020 | 1.947M |
| December 31, 2019 | 1.919M |
| Date | Value |
|---|---|
| September 30, 2019 | 2.595M |
| June 30, 2019 | 2.813M |
| March 31, 2019 | 3.270M |
| December 31, 2018 | 2.541M |
| September 30, 2018 | 1.30M |
| June 30, 2018 | 0.54M |
| March 31, 2018 | 0.8317M |
| December 31, 2017 | 0.659M |
| September 30, 2017 | 0.3857M |
| June 30, 2017 | 1.309M |
| March 31, 2017 | 0.9181M |
| December 31, 2016 | 0.8137M |
| September 30, 2016 | 0.756M |
| June 30, 2016 | 0.71M |
| March 31, 2016 | 1.169M |
| December 31, 2015 | 0.7228M |
| September 30, 2015 | 0.7223M |
| June 30, 2015 | 0.7029M |
| March 31, 2015 | 0.6858M |
| December 31, 2014 | 0.69M |
| September 30, 2014 | 0.7166M |
| June 30, 2014 | 0.5106M |
| March 31, 2014 | 0.5152M |
| December 31, 2013 | 0.6003M |
| September 30, 2013 | 0.1317M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Quest PharmaTech, Inc. | 1.329M |
| BriaCell Therapeutics Corp. | 4.985M |
| Vaxil Bio Ltd. | 0.03M |
| Waverley Pharma, Inc. | 3.920M |
| Goldcoast Resource Corp. | 0.1372M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.811M |
| Shareholders Equity (Quarterly) | -1.418M |
| Debt to Equity Ratio | -1.352 |
| Current Ratio | 0.4535 |
| Net Debt Paydown Yield | 1.34% |